Chronic spontaneous urticaria is characterized by lower serum advanced glycation end-products

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Grzanka, Alicja ^a   Damasiewicz Bodzek, Aleksandra ^a   Machura, Edyta ^a   Szumska, Magdalena ^a   Tyrpień Golder, Krystyna ^a   Mazur, Bogdan ^a   Kasperska Zajac, Alicja ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ACUTE PHASE RESPONSE; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CHRONIC DISEASE; CHRONIC INFLAMMATION; CHRONIC SPONTANEOUS URTICARIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; SPECTROFLUOROMETRY; URTICARIA; BLOOD; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; BIOMARKERS; CHRONIC DISEASE; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URTICARIA;

EID: 84907409970     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/974154     Document Type: Article

References (25)

1. R. A. Sabroe, C. E. H. Grattan, D. M. Francis, R. M. Barr, A. Kobza Black, and M. W. Greaves, "The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria," The British Journal of Dermatology, vol. 140, no. 3, pp. 446-452, 1999.
2. D. H. Dreyfus, "Autoimmune disease: a role for new anti-viral therapies?" Autoimmunity Reviews, vol. 11, no. 2, pp. 88-97, 2011.
3. B. Wedi, U. Raap, D. Wieczorek, and A. Kapp, "Urticaria and Infections," Allergy, Asthma & Clinical Immunology, vol. 5, article 10, 2009.
4. S. Takahagi, S. Mihara, K. Iwamoto et al., "Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria," Allergy, vol. 65, no. 5, pp. 649-656, 2010.
5. A. Kasperska-Zajac, J. Sztylc, E. Machura, and G. Jop, "Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients," Clinical and Experimental Allergy, vol. 41, no. 10, pp. 1386-1391, 2011.
6. R. Asero, M. Cugno, and A. Tedeschi, "Activation of blood coagulation in plasma from chronic urticaria patients with negative autologous plasma skin test," Journal of the European Academy of Dermatology andVenereology, vol. 25,no. 2, pp. 201-205, 2011.
7. A. Kasperska-Zaja¸c, Z. Brzoza, and B. Rogala, "Serum concentration of dehydroepiandrosterone sulphate in female patients with chronic idiopathic urticaria," Journal of Dermatological Science, vol. 41, no. 1, pp. 80-81, 2006.
8. A. Kasperska-Zajac, A. Grzanka, E. Machura et al., "Analysis of procalcitonin and CRP concentrations in serumof patients with chronic spontaneous urticaria," Inflammation Research, vol. 62, no. 3, pp. 309-312, 2013.
9. R. Darlenski, J. Kazandjieva, T. Zuberbier, and N. Tsankov, "Chronic urticaria as a systemic disease," Clinics in Dermatology, vol. 32, pp. 420-423, 2014.
10. Y. K. Chuah, R. Basir, H. Talib, T. H. Tie, and N. Nordin, "Receptor for advanced glycation end products and its involvement in inflammatory diseases," International Journal of Inflammation, vol. 2013, Article ID403460, 15 pages, 2013.
11. E. Nur, D. P. Brandjes, J. B. Schnog et al., "Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients," British Journal of Haematology, vol. 151, no. 1, pp. 62-69, 2010.
12. O. Nedić, S. I. S. Rattan, T. Grune, and I. P. Trougakos, "Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology," Free Radical Research, vol. 47, supplement 1, pp. 28-38, 2013.
13. H. L. A. Nienhuis, J. Westra, A. J. Smit, P. C. Limburg, C. G. M. Kallenberg, and M. Bijl, "AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis," Autoimmunity, vol. 42, no. 4, pp. 302-304, 2009.
14. A. Hirose, T. Tanikawa, H. Mori, Y. Okada, and Y. Tanaka, "Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway," FEBS Letters, vol. 584, no. 1, pp. 61-66, 2010.
15. S. Arsov, R. Graaff, W. van Oeveren et al., "Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review," Clinical Chemistry and Laboratory Medicine, vol. 52, pp. 11-20, 2014.
16. J. Li, F. Hou, Z. Guo, Y. Shan, X. Zhang, and Z. Liu, "Advanced glycation end products upregulate C-reactive protein synthesis by human hepatocytes through stimulation of monocyte IL-6 and IL-1β production," Scandinavian Journal of Immunology, vol. 66, no. 5, pp. 555-562, 2007.
17. A. Kasperska-Zajac, "Acute-phase response in chronic urticaria," Journal of the European Academy of Dermatology and Venereology, vol. 26, no. 6, pp. 665-672, 2012.
18. M. P. Margarson and N. Soni, "Serum albumin: touchstone or totem?" Anaesthesia, vol. 53, no. 8, pp. 789-803, 1998.
19. Y. Huang, H. Shinzawa, H. Togashi et al., "Interleukin-6 downregulates expressions of the aldolase B and albumin genes through a pathway involving the activation of tyrosine kinase," Archives of Biochemistry and Biophysics, vol. 320, no. 2, pp. 203-209, 1995.
20. A. Kasperska-Zajac, A. Grzanka, E. Machura, M. Misiolek, B. Mazur, and J. Jochem, "Increased serum complement C3 and C4 concentrations and their relation to severity of chronic spontaneous urticaria and CRP concentration," Journal of Inflammation, vol. 10, no. 1, article 22, 2013.
21. A. Kasperska-Zaja¸c, A. Grzanka, E. Czecior, M. Misiolek, B. Rogala, and E. Machura, "Acute phase inflammatory markers in patients with non-steroidal anti-inflammatory drugs (NSAIDs)-induced acute urticaria/angioedema and after aspirin challenge," Journal of the European Academy of Dermatology and Venereology, vol. 27, no. 8, pp. 1048-1052, 2013.
22. M. Krajcovicová-Kudlácková, K. Sebeková, R. Schinzel, and J. Klvanová, "Advanced glycation end products and nutrition," Physiological Research, vol. 51, pp. 313-316, 2002.
23. S. Zilin, L. Naifeng, L. Bicheng, and W. Jiping, "The determination of AGE-peptides by flow injection assay, a practical marker of diabetic nephropathy," Clinica Chimica Acta, vol. 313, no. 1-2, pp. 69-75, 2001.
24. R. Bucala and H. Vlassara, "Advanced glycosylation end products in diabetic renal and vascular disease," American Journal of Kidney Diseases, vol. 26, no. 6, pp. 875-888, 1995.
25. G. Di Lorenzo, P. L. Minciullo, M. S. Leto-Barone et al., "Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis," Journal of Investigational Allergology and Clinical Immunology, vol. 23, no. 2, pp. 101-106, 2013.